Company Filing History:
Years Active: 2008
Title: David Chien: Innovator in Immunology
Introduction
David Chien is a prominent inventor based in Los Altos, California. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of human receptors and membrane-associated proteins that have important implications for diagnosing and treating various disorders.
Latest Patents
David Chien holds a patent for a CD40-related receptor that binds CD40L. This invention encompasses various embodiments that provide human receptors and membrane-associated proteins (REMAP) and Q polynucleotides, which identify and encode REMAP. Additionally, the patent includes expression vectors, host cells, antibodies, agonists, and antagonists. The methods outlined in the patent aim to diagnose, treat, or prevent disorders associated with aberrant expression of REMAP. He has 1 patent to his name.
Career Highlights
David Chien is currently associated with Incyte Corporation, where he continues to advance his research in immunology. His work at Incyte has positioned him as a key player in the development of innovative therapeutic solutions.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Narinder K Chawla and Henry Yue. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field.
Conclusion
David Chien's contributions to immunology through his patent and work at Incyte Corporation highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in medical science.